Scholarlink

<p>Studies on murine models show that <i>Toxoplasma gondii</i> infection reduces cerebral microvascular perfusion and induces neuroinflammation by activating cerebral endothelial cells, which could affect traumatic brain injury (TBI) outcomes. Whether TBI inflammatory profile and outcomes differ in persons with concurrent latent infection with <i>Toxoplasma gondii</i> has not yet been elucidated in TBI patients, constituting the core of this study. Understanding the impact of chronic <i>T. gondii</i> infection on neuroinflammation after TBI may ensure better management and prognosis of TBI. This study aimed to investigate the inflammatory profile in TBI patients and investigate the influence of concurrent <i>T. gondii</i> infection on inflammatory markers and TBI outcomes. The level of inflammatory markers [interleukin (IL)-1β, IL-6, IL-10, interferon-gamma (INF-ɣ), Tumour necrosis factor-alpha (TNF-α)], and <i>Toxoplasma gondii</i> infection were detected in serum obtained &lt; 24&#xa0;h post-injury. Glasgow Outcome Scale-Extended (GOSE) was used to evaluate the 6-month outcome post-discharge. The Wilcoxon and Kruskal-Wallis’s rank sum tests were used to compare concentrations of inflammatory markers to <i>T. gondii infection</i> and TBI outcome. <i>T. gondii</i> infection was detected in 33% (52/160) of TBI cases. There was a significant increase (<i>p</i> &lt; 0.001) in the concentrations of all inflammatory markers (IM) in TBI patients compared with the healthy controls. Higher levels of IL-6, INF-ɣ, and TNF-α were associated with mortality. Findings from this study show an increase in IM levels for all the <i>T. gondii-positive</i> TBI cases, which were significant for IL-1β (<i>P</i> &lt; 0.001) and TNF-α (<i>P</i> &lt; 0.001). IL-1β and TNF-α, had significantly greater density values, above 30pg/mL and 90pg/mL, respectively, in TBI patients infected with <i>T. gondii</i>, compared to greater density values, below 30 pg/mL and 90 pg/mL, respectively, for TBI patients seronegative to <i>T. gondii.</i> Concurrent <i>T. gondii</i> infection in TBI significantly influenced the inflammation profile of patients. Further multicenter studies with larger sample sizes will provide more insights into <i>T. gondii</i> induced neuropathology and prognostication in TBI care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Concurrent Toxoplasma gondii infection and neuroinflammation in traumatic brain injury patients in a referral hospital in Douala Cameroon

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月12日

查看全文
  • Franklin Chu Buh,
  • Germain Sotoing Taiwe,
  • Andrew I. R. Maas,
  • Mathieu Motah,
  • Ignatius Esene,
  • Firas H. Kobeissy,
  • Vanessa Tita Jugha,
  • Eric Youm,
  • Basil Kum Meh,
  • Kevin W. Wang,
  • Peter J. A. Hutchinson,
  • Irene Ule Ngole Sumbele

摘要

Studies on murine models show that Toxoplasma gondii infection reduces cerebral microvascular perfusion and induces neuroinflammation by activating cerebral endothelial cells, which could affect traumatic brain injury (TBI) outcomes. Whether TBI inflammatory profile and outcomes differ in persons with concurrent latent infection with Toxoplasma gondii has not yet been elucidated in TBI patients, constituting the core of this study. Understanding the impact of chronic T. gondii infection on neuroinflammation after TBI may ensure better management and prognosis of TBI. This study aimed to investigate the inflammatory profile in TBI patients and investigate the influence of concurrent T. gondii infection on inflammatory markers and TBI outcomes. The level of inflammatory markers [interleukin (IL)-1β, IL-6, IL-10, interferon-gamma (INF-ɣ), Tumour necrosis factor-alpha (TNF-α)], and Toxoplasma gondii infection were detected in serum obtained < 24 h post-injury. Glasgow Outcome Scale-Extended (GOSE) was used to evaluate the 6-month outcome post-discharge. The Wilcoxon and Kruskal-Wallis’s rank sum tests were used to compare concentrations of inflammatory markers to T. gondii infection and TBI outcome. T. gondii infection was detected in 33% (52/160) of TBI cases. There was a significant increase (p < 0.001) in the concentrations of all inflammatory markers (IM) in TBI patients compared with the healthy controls. Higher levels of IL-6, INF-ɣ, and TNF-α were associated with mortality. Findings from this study show an increase in IM levels for all the T. gondii-positive TBI cases, which were significant for IL-1β (P < 0.001) and TNF-α (P < 0.001). IL-1β and TNF-α, had significantly greater density values, above 30pg/mL and 90pg/mL, respectively, in TBI patients infected with T. gondii, compared to greater density values, below 30 pg/mL and 90 pg/mL, respectively, for TBI patients seronegative to T. gondii. Concurrent T. gondii infection in TBI significantly influenced the inflammation profile of patients. Further multicenter studies with larger sample sizes will provide more insights into T. gondii induced neuropathology and prognostication in TBI care.